Leading Our Life
Sciences Community

Boosting Nova Scotia’s
Global Profile

Driving Our
Bio-Economy Forward


First Patient Dosed in Phase 1 Clinical Trial Evaluating Neoepitopes Formulated in IMV’s DPX Delivery Platform in Ovarian Cancer Patients

Read original release here January 17, 2019 at 7:05 AM EST DARTMOUTH, Nova Scotia, Jan. 17, 2019 (GLOBE NEWSWIRE) -- IMV Inc. (Nasdaq: IMV; ...
Read More

Sona Nanotech Inc. Announces Collaboration with Anteo Technologies

Read original release here Innovative companies combine technologies to speed up lateral flow assay development time Halifax, Nova Scotia–(Newsfile Corp ...
Read More



Friday, January 18th, 2019 at 10:16am
We're thrilled to see a more competitive tax credit for Nova Scotia to boost investment in the life science sector which will drive innovation and create high-value jobs for Nova Scotians. https://t.co/B9H2ppkqtD
Thursday, January 17th, 2019 at 5:03pm
Province Announces Innovation Equity Tax Credit with an increase of $200,000 and Nova Scotian investors receiving 45 per cent in priority sectors of oceans technology and life science. https://t.co/NvFRqwLDk4
Thursday, January 17th, 2019 at 2:08pm
Congrats to @imv_inc on launching Phase 1 patient trials for ovarian cancer from their DPX Delivery Platform. Amazing health innovations coming from Nova Scotia! https://t.co/f7mZXpq433
Wednesday, January 16th, 2019 at 12:56pm
Congrats to @SonaNanotech on your collaboration with Australia-based nanotech company @AnteoTech to work towards bringing innovative new products to market worldwide. https://t.co/f4QjNZFpr9
Tuesday, January 15th, 2019 at 10:51am
High-value sectors like Health and Life Science create high-value jobs for Nova Scotians. We're here to continue to boost the innovation economy and bring health solutions and prosperity for the region. https://t.co/k3Y6UNsmhU
Thursday, January 10th, 2019 at 10:59am
The Government of Canada created and tasked the Health & Biosciences Economic Strategy Table to develop sector-wide actions to unleash Canadian innovation in our industry. Click here for more information, and to express your support: https://t.co/KZHJbnY96a
  • Pharmaceuticals & Vaccines

    Innovative drugs and therapies for the treatment or prevention of disease.

  • Medical Technologies

    Used in the diagnosis and treatment of medical conditions and include medical devices, diagnostic imaging, invitro diagnostics, therapeutic and assistive devices.

  • Digital Health

    The intersection of healthcare and technology resulting in technologies to support mobile health, wearables and implantables, remote patient monitoring, big data analytics to support self-directed healthcare and personalized medicine.

  • Natural Health Products

    Used to restore or maintain good health and are sourced from naturally occurring biological resources such as omega-3 fatty acids.

  • BioProducts

    High value products derived from biologically sourced materials (bioresources) such as biofuels, biomaterials, biochemicals, bioplastics and bioenergy that serve many commercial markets.

Our Acceleration Initiatives

BioNova aims to accelerate the innovation and productivity of businesses in Nova Scotia’s bioeconomy through our Projects, Programs, Services & Events with the support of our stakeholders and funding partners.